Sort   by:  
 Page size 
UnknownFactors influencing evidence-based cardiovascular disease prevention programming in rural African American communities: a community-engaged concept mapping study.
Not available
S-EPMC11742505 | biostudies-literature
UnknownVersatile acid solvents for pristine carbon nanotube assembly.
Not available
S-EPMC9045610 | biostudies-literature
UnknownChronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
Not available
S-EPMC4818564 | biostudies-literature
UnknownSystematic evidence map (SEM) template: Report format and methods used for the US EPA Integrated Risk Information System (IRIS) program, Provisional Peer Reviewed Toxicity Value (PPRTV) program, and other "fit for purpose" literature-based human health analyses.
Not available
S-EPMC12044641 | biostudies-literature
UnknownAnti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial.
Not available
S-EPMC11581602 | biostudies-literature
UnknownVariants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Not available
S-EPMC2692559 | biostudies-literature
UnknownProlonged therapy of advanced chronic hepatitis C with low-dose peginterferon.
Not available
S-EPMC2606037 | biostudies-literature
UnknownOccult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C.
Not available
S-EPMC3134544 | biostudies-literature
UnknownCoffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
Not available
S-EPMC2783828 | biostudies-literature
UnknownIncidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Not available
S-EPMC3749922 | biostudies-literature
Sort   by:  
 Page size